Home > Patients, Caregivers, and Advocates > Progress Against Cancer > Research
Study found teclistamab-cqyv, an immunotherapy, led to responses in patients with high-risk, heavily pretreated multiple myeloma, including after prior BCMA therapy. Teclistamab-cqyv (Tecvayli), a type of immunotherapy, received accelerated approval from the U.S. Food...
Incidence-based mortality is also projected to increase with disproportionately higher rates for Black women compared with white women. Incidence and mortality rates for most cancer types have been on the decline in the United...
Learn how a Gleason score is calculated to help determine the aggressiveness of prostate cancer, and how it could influence a patient's treatment.
The largest increases were found in breast, colorectal, endometrial, pancreatic, and kidney cancers. Early-onset cancers, or cancers diagnosed in individuals under the age of 50, are rising in the United States. While the exact...
A recently approved first-line therapy and novel insights into optimizing treatment strategies may offer new options for esophageal cancer patients.
After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he started radiation therapy. His oncologist told him he might be eligible for targeted therapy, but...
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
Natalie Snider-Hoy, a PhD candidate at Wayne State University, attended AACR Early-career Hill Day 2025 to advocate for sustained NIH funding.
Radiation plus immunotherapy may help some patients with invasive bladder cancer keep their bladders. Patients with localized muscle-invasive bladder cancer (MIBC), or bladder cancer that has spread through the lining of the bladder and...
A therapeutic HPV vaccine showed remarkable benefits for patients with high-grade cervical precancers.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now